Literature DB >> 27799464

Muscle injury, impaired muscle function and insulin resistance in Chromogranin A-knockout mice.

Kechun Tang1, Teresa Pasqua1, Angshuman Biswas1, Sumana Mahata2, Jennifer Tang1, Alisa Tang1, Gautam K Bandyopadhyay1, Amiya P Sinha-Hikim3,4, Nai-Wen Chi1,5, Nicholas J G Webster1,5, Angelo Corti6, Sushil K Mahata7,5.   

Abstract

Chromogranin A (CgA) is widely expressed in endocrine and neuroendocrine tissues as well as in the central nervous system. We observed CgA expression (mRNA and protein) in the gastrocnemius (GAS) muscle and found that performance of CgA-deficient Chga-KO mice in treadmill exercise was impaired. Supplementation with CgA in Chga-KO mice restored exercise ability suggesting a novel role for endogenous CgA in skeletal muscle function. Chga-KO mice display (i) lack of exercise-induced stimulation of pAKT, pTBC1D1 and phospho-p38 kinase signaling, (ii) loss of GAS muscle mass, (iii) extensive formation of tubular aggregates (TA), (iv) disorganized cristae architecture in mitochondria, (v) increased expression of the inflammatory cytokines Tnfα, Il6 and Ifnγ, and fibrosis. The impaired maximum running speed and endurance in the treadmill exercise in Chga-KO mice correlated with decreased glucose uptake and glycolysis, defects in glucose oxidation and decreased mitochondrial cytochrome C oxidase activity. The lack of adaptation to endurance training correlated with the lack of stimulation of p38MAPK that is known to mediate the response to tissue damage. As CgA sorts proteins to the regulated secretory pathway, we speculate that lack of CgA could cause misfolding of membrane proteins inducing aggregation of sarcoplasmic reticulum (SR) membranes and formation of tubular aggregates that is observed in Chga-KO mice. In conclusion, CgA deficiency renders the muscle energy deficient, impairs performance in treadmill exercise and prevents regeneration after exercise-induced tissue damage.
© 2017 Society for Endocrinology.

Entities:  

Keywords:  glucose metabolism; insulin signaling; mitochondria; skeletal muscle; tubular aggregates

Mesh:

Substances:

Year:  2016        PMID: 27799464      PMCID: PMC5287349          DOI: 10.1530/JOE-16-0370

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  91 in total

1.  PHOSPHOFRUCTOKINASE DEFICIENCY IN SKELETAL MUSCLE. A NEW TYPE OF GLYCOGENOSIS.

Authors:  S TARUI; G OKUNO; Y IKURA; T TANAKA; M SUDA; M NISHIKAWA
Journal:  Biochem Biophys Res Commun       Date:  1965-05-03       Impact factor: 3.575

2.  Tubular aggregates in paralysis periodica paramyotonica with T704M mutation of SCN4A.

Authors:  Xinghua Luan; Bin Chen; Yang Liu; Riliang Zheng; Wei Zhang; Yun Yuan
Journal:  Neuropathology       Date:  2008-12-03       Impact factor: 1.906

3.  Mitochondrial biogenesis during skeletal muscle regeneration.

Authors:  Stéphanie Duguez; Léonard Féasson; Christian Denis; Damien Freyssenet
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-04       Impact factor: 4.310

4.  Electrophysiologic and histochemical observations in five patients with muscle phosphorylase deficiency (MPD).

Authors:  T E Bertorini; R A Brumback; R W Kula; W K Engel
Journal:  Trans Am Neurol Assoc       Date:  1977

5.  Expression of heat shock protein epitopes in tubular aggregates.

Authors:  J E Martin; K Mather; M Swash; A B Gray
Journal:  Muscle Nerve       Date:  1991-03       Impact factor: 3.217

6.  Glucose transporter number, activity, and isoform content in plasma membranes of red and white skeletal muscle.

Authors:  L J Goodyear; M F Hirshman; R J Smith; E S Horton
Journal:  Am J Physiol       Date:  1991-11

7.  The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism.

Authors:  Tommaso Angelone; Anna Maria Quintieri; Bhawanjit K Brar; Pauline T Limchaiyawat; Bruno Tota; Sushil K Mahata; Maria Carmela Cerra
Journal:  Endocrinology       Date:  2008-06-05       Impact factor: 4.736

8.  Pax3 and Pax7 have distinct and overlapping functions in adult muscle progenitor cells.

Authors:  Frédéric Relaix; Didier Montarras; Stéphane Zaffran; Barbara Gayraud-Morel; Didier Rocancourt; Shahragim Tajbakhsh; Ahmed Mansouri; Ana Cumano; Margaret Buckingham
Journal:  J Cell Biol       Date:  2005-12-27       Impact factor: 10.539

9.  Insulin stimulation regulates AS160 and TBC1D1 phosphorylation sites in human skeletal muscle.

Authors:  R J W Middelbeek; M A Chambers; P Tantiwong; J T Treebak; D An; M F Hirshman; N Musi; L J Goodyear
Journal:  Nutr Diabetes       Date:  2013-06-10       Impact factor: 5.097

Review 10.  The chromogranins A and B: the first 25 years and future perspectives.

Authors:  H Winkler; R Fischer-Colbrie
Journal:  Neuroscience       Date:  1992-08       Impact factor: 3.590

View more
  2 in total

Review 1.  Chromogranin A Regulation of Obesity and Peripheral Insulin Sensitivity.

Authors:  Gautam K Bandyopadhyay; Sushil K Mahata
Journal:  Front Endocrinol (Lausanne)       Date:  2017-02-08       Impact factor: 5.555

2.  Cardiac-specific loss of mitoNEET expression is linked with age-related heart failure.

Authors:  Takaaki Furihata; Shingo Takada; Naoya Kakutani; Satoshi Maekawa; Masaya Tsuda; Junichi Matsumoto; Wataru Mizushima; Arata Fukushima; Takashi Yokota; Nobuyuki Enzan; Shouji Matsushima; Haruka Handa; Yoshizuki Fumoto; Junko Nio-Kobayashi; Toshihiko Iwanaga; Shinya Tanaka; Hiroyuki Tsutsui; Hisataka Sabe; Shintaro Kinugawa
Journal:  Commun Biol       Date:  2021-01-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.